1. Home
  2. RLMD vs MHUA Comparison

RLMD vs MHUA Comparison

Compare RLMD & MHUA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • MHUA
  • Stock Information
  • Founded
  • RLMD 2004
  • MHUA 1990
  • Country
  • RLMD United States
  • MHUA China
  • Employees
  • RLMD N/A
  • MHUA N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • MHUA Medical Specialities
  • Sector
  • RLMD Health Care
  • MHUA Health Care
  • Exchange
  • RLMD Nasdaq
  • MHUA Nasdaq
  • Market Cap
  • RLMD 20.3M
  • MHUA 19.6M
  • IPO Year
  • RLMD N/A
  • MHUA 2022
  • Fundamental
  • Price
  • RLMD $0.59
  • MHUA $0.37
  • Analyst Decision
  • RLMD Buy
  • MHUA
  • Analyst Count
  • RLMD 3
  • MHUA 0
  • Target Price
  • RLMD $5.00
  • MHUA N/A
  • AVG Volume (30 Days)
  • RLMD 206.5K
  • MHUA 166.6K
  • Earning Date
  • RLMD 08-07-2025
  • MHUA 09-19-2025
  • Dividend Yield
  • RLMD N/A
  • MHUA N/A
  • EPS Growth
  • RLMD N/A
  • MHUA N/A
  • EPS
  • RLMD N/A
  • MHUA 0.40
  • Revenue
  • RLMD N/A
  • MHUA $96,909,642.00
  • Revenue This Year
  • RLMD N/A
  • MHUA N/A
  • Revenue Next Year
  • RLMD N/A
  • MHUA N/A
  • P/E Ratio
  • RLMD N/A
  • MHUA $0.96
  • Revenue Growth
  • RLMD N/A
  • MHUA N/A
  • 52 Week Low
  • RLMD $0.24
  • MHUA $0.25
  • 52 Week High
  • RLMD $3.98
  • MHUA $1.26
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 44.70
  • MHUA 39.91
  • Support Level
  • RLMD $0.60
  • MHUA $0.38
  • Resistance Level
  • RLMD $0.67
  • MHUA $0.41
  • Average True Range (ATR)
  • RLMD 0.06
  • MHUA 0.03
  • MACD
  • RLMD -0.00
  • MHUA -0.01
  • Stochastic Oscillator
  • RLMD 16.42
  • MHUA 9.10

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About MHUA Meihua International Medical Technologies Co. Ltd.

Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.

Share on Social Networks: